Report cover image

Next Generation Antibody Drug Global Market Report 2025

Published Jul 01, 2025
Length 175 Pages
SKU # BRC20148781

Description

Next Generation Antibody Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next generation antibody drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for next generation antibody drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The next generation antibody drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product Type: Monoclonal Antibodies; Bispecific Antibodies; Antibody-Drug Conjugates; Other Types

2) By Mechanism Of Action: Checkpoint Inhibitors; Immune Modulators; Receptor Blockers; Targeted Cytotoxic Agents; Neutralizing Antibodies

3) By Delivery Method: Intravenous (IV) Administration; Subcutaneous Administration; Intramuscular Administration; Oral Formulations; Transdermal Delivery Systems

4) By Application: Oncology; Autoimmune Diseases; Infectious Diseases; Other Applications

5) By End User: Hospitals; Research Institutes; Specialty Clinics; Other End Users

Subsegments:

1) By Monoclonal Antibodies: Human Monoclonal Antibodies; Murine Monoclonal Antibodies; Humanized Monoclonal Antibodies; Chimeric Monoclonal Antibodies

2) By Bispecific Antibodies: Checkpoint Inhibitor-Based Bispecifics; Bispecific Antibodies For Cytokine Modulation; Bispecific Antibodies With Extended Half-Life Technologies

3) By Antibody-Drug Conjugates: Cleavable Linker Antibody-Drug Conjugates; Non-Cleavable Linker Antibody-Drug Conjugates; Site-Specific Conjugated Antibody-Drug Conjugates

Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Bristol-Myers Squibb Company; AstraZeneca plc; GlaxoSmithKline plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Next Generation Antibody Drug Market Characteristics
3. Next Generation Antibody Drug Market Trends And Strategies
4. Next Generation Antibody Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Next Generation Antibody Drug Growth Analysis And Strategic Analysis Framework
5.1. Global Next Generation Antibody Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Next Generation Antibody Drug Market Growth Rate Analysis
5.4. Global Next Generation Antibody Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Next Generation Antibody Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Next Generation Antibody Drug Total Addressable Market (TAM)
6. Next Generation Antibody Drug Market Segmentation
6.1. Global Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Bispecific Antibodies
Antibody-Drug Conjugates
Other Types
6.2. Global Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Checkpoint Inhibitors
Immune Modulators
Receptor Blockers
Targeted Cytotoxic Agents
Neutralizing Antibodies
6.3. Global Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous (IV) Administration
Subcutaneous Administration
Intramuscular Administration
Oral Formulations
Transdermal Delivery Systems
6.4. Global Next Generation Antibody Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Autoimmune Diseases
Infectious Diseases
Other Applications
6.5. Global Next Generation Antibody Drug Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Institutes
Specialty Clinics
Other End Users
6.6. Global Next Generation Antibody Drug Market, Sub-Segmentation Of Monoclonal Antibodies, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Monoclonal Antibodies
Murine Monoclonal Antibodies
Humanized Monoclonal Antibodies
Chimeric Monoclonal Antibodies
6.7. Global Next Generation Antibody Drug Market, Sub-Segmentation Of Bispecific Antibodies, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Checkpoint Inhibitor-Based Bispecifics
Bispecific Antibodies For Cytokine Modulation
Bispecific Antibodies With Extended Half-Life Technologies
T-Cell Engagers
6.8. Global Next Generation Antibody Drug Market, Sub-Segmentation Of Antibody-Drug Conjugates, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cleavable Linker Antibody-Drug Conjugates
Non-Cleavable Linker Antibody-Drug Conjugates
Site-Specific Conjugated Antibody-Drug Conjugates
6.9. Global Next Generation Antibody Drug Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Teclistamab
Mosunetuzumab
7. Next Generation Antibody Drug Market Regional And Country Analysis
7.1. Global Next Generation Antibody Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Next Generation Antibody Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Next Generation Antibody Drug Market
8.1. Asia-Pacific Next Generation Antibody Drug Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Next Generation Antibody Drug Market
9.1. China Next Generation Antibody Drug Market Overview
9.2. China Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Next Generation Antibody Drug Market
10.1. India Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Next Generation Antibody Drug Market
11.1. Japan Next Generation Antibody Drug Market Overview
11.2. Japan Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Next Generation Antibody Drug Market
12.1. Australia Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Next Generation Antibody Drug Market
13.1. Indonesia Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Next Generation Antibody Drug Market
14.1. South Korea Next Generation Antibody Drug Market Overview
14.2. South Korea Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Next Generation Antibody Drug Market
15.1. Western Europe Next Generation Antibody Drug Market Overview
15.2. Western Europe Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Next Generation Antibody Drug Market
16.1. UK Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Next Generation Antibody Drug Market
17.1. Germany Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Next Generation Antibody Drug Market
18.1. France Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Next Generation Antibody Drug Market
19.1. Italy Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Next Generation Antibody Drug Market
20.1. Spain Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Next Generation Antibody Drug Market
21.1. Eastern Europe Next Generation Antibody Drug Market Overview
21.2. Eastern Europe Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Next Generation Antibody Drug Market
22.1. Russia Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Next Generation Antibody Drug Market
23.1. North America Next Generation Antibody Drug Market Overview
23.2. North America Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Next Generation Antibody Drug Market
24.1. USA Next Generation Antibody Drug Market Overview
24.2. USA Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Next Generation Antibody Drug Market
25.1. Canada Next Generation Antibody Drug Market Overview
25.2. Canada Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Next Generation Antibody Drug Market
26.1. South America Next Generation Antibody Drug Market Overview
26.2. South America Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Next Generation Antibody Drug Market
27.1. Brazil Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Next Generation Antibody Drug Market
28.1. Middle East Next Generation Antibody Drug Market Overview
28.2. Middle East Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Next Generation Antibody Drug Market
29.1. Africa Next Generation Antibody Drug Market Overview
29.2. Africa Next Generation Antibody Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Next Generation Antibody Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Next Generation Antibody Drug Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Next Generation Antibody Drug Market Competitive Landscape And Company Profiles
30.1. Next Generation Antibody Drug Market Competitive Landscape
30.2. Next Generation Antibody Drug Market Company Profiles
30.2.1. Actinium Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Next Generation Antibody Drug Market Other Major And Innovative Companies
31.1. GlaxoSmithKline plc
31.2. Takeda Pharmaceutical Company Limited
31.3. Gilead Sciences Inc.
31.4. Amgen Inc.
31.5. Boehringer Ingelheim International GmbH
31.6. Regeneron Pharmaceuticals Inc.
31.7. Biogen Inc.
31.8. Kyowa Hakko Kirin Co. Ltd.
31.9. Samsung Biologics Co. Ltd.
31.10. WuXi Biologics Inc.
31.11. Akeso Inc.
31.12. Xencor Inc.
31.13. ImmunoGen Inc.
31.14. Philogen S.p.A.
31.15. Telix Pharmaceuticals Limited
32. Global Next Generation Antibody Drug Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Next Generation Antibody Drug Market
34. Recent Developments In The Next Generation Antibody Drug Market
35. Next Generation Antibody Drug Market High Potential Countries, Segments and Strategies
35.1 Next Generation Antibody Drug Market In 2029 - Countries Offering Most New Opportunities
35.2 Next Generation Antibody Drug Market In 2029 - Segments Offering Most New Opportunities
35.3 Next Generation Antibody Drug Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.